Most state Medicaid programs don’t cover the new class of weight loss drugs for obesity ... While all state Medicaid programs cover GLP-1 agonists for type 2 diabetes, it’s much less common ...
So, if you're looking for exposure to the growth of the weight loss market but are loath ... making it highly differentiated from GLP-1 drugs. That program will soon enter phase 2b clinical ...
A recent study found semaglutide – the drug known as Ozempic – can improve knee pain in people with obesity and ...
Glucagon-like peptide medications that treat Type 2 diabetes and weight management continue to grow in popularity, though ...
UPI News on MSN18d
Weight-loss surgeries decline 25% as GLP-1 drugs grow in popularityPrescriptions of this GLP-1 class of diabetes and weight-loss medications more than doubled between 2022 ... "Anecdotally, ...
MedPage Today on MSN1d
ObesityWeek Roundup: Patients More Likely to Ration Weight-Loss DrugsSAN ANTONIO -- Research presented at the ObesityWeek annual meeting included studies on rationing of prescription medications ...
Drug developer Endevica Bio is spinning off a new company, Abisati, to focus solely on one promising weight-loss treatment. Northbrook-based Endevica has found its peptide drug candidate 710GO, an ...
Perrigo intends to put focus at select retailers on over-the-counter medications that relieve the side effects of GLP-1 drugs ...
Maryland’s policymakers should expand Medicaid coverage to include weight loss medications, writes Michelle Rogers.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback